Casi Pharma rises on lower Q1 loss
17/05/2023 17:27
** Shares of U.S. drug developer Casi Pharmaceuticals Inc
CASI.O up 7% at $2.60
** Q1 net loss dropped to $5.8 mln, from a net loss of $8.4
mln a year earlier
** Expects to fund current operations beyond Q1 of 2024 with
$44.8 mln in cash, cash equivalents and investments
** CASI stock up 34.08% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary